Home
>
National Drug Code (NDC)
>
Gemcitabine hydrochloride
Gemcitabine hydrochloride - 23155-213-31 - (Gemcitabine hydrochloride)
Drug Information of Gemcitabine hydrochloride
| Product NDC: | 23155-213 |
| Proprietary Name: | Gemcitabine hydrochloride |
| Non Proprietary Name: | Gemcitabine hydrochloride |
| Active Ingredient(s): | 200 mg/5mL & nbsp; Gemcitabine hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Gemcitabine hydrochloride
| Product NDC: | 23155-213 |
| Labeler Name: | Heritage Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202063 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121022 |
Package Information of Gemcitabine hydrochloride
| Package NDC: | 23155-213-31 |
| Package Description: | 1 VIAL, GLASS in 1 CARTON (23155-213-31) > 5 mL in 1 VIAL, GLASS |
NDC Information of Gemcitabine hydrochloride
| NDC Code | 23155-213-31 |
| Proprietary Name | Gemcitabine hydrochloride |
| Package Description | 1 VIAL, GLASS in 1 CARTON (23155-213-31) > 5 mL in 1 VIAL, GLASS |
| Product NDC | 23155-213 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Gemcitabine hydrochloride |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20121022 |
| Marketing Category Name | ANDA |
| Labeler Name | Heritage Pharmaceuticals Inc. |
| Substance Name | GEMCITABINE HYDROCHLORIDE |
| Strength Number | 200 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
